Brian S. Johnson

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

Andrew C. Elden, Hyung Jun Kim, Michael P. Hart et al. · Nature · 2010 · 1.3K citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Molecular Neuroscience +6

TDP-43 Is Intrinsically Aggregation-prone, and Amyotrophic Lateral Sclerosis-linked Mutations Accelerate Aggregation and Increase Toxicity

Brian S. Johnson, David Snead, Jonathan J. Lee et al. · Journal of Biological Chemistry · 2009 · 787 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Increase Toxicity +10

A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity

Brian S. Johnson, J. Michael McCaffery, Susan Lindquist et al. · Proceedings of the National Academy of Sciences · 2008 · 418 citations · Full text

Molecular Biology, Cell Death, Toxicological Mechanism +20

Prion-like disorders: blurring the divide between transmissibility and infectivity

Mimi Cushman, Brian S. Johnson, Oliver D. King et al. · Journal of Cell Science · 2010 · 278 citations

Health service accreditation as a predictor of clinical and organisational performance: a blinded, random, stratified study

Jeffrey Braithwaite, David Greenfield, Johanna Westbrook et al. · BMJ Quality & Safety · 2010 · 187 citations